OR WAIT null SECS
© 2021 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2021 MJH Life Sciences™ and Formulary Watch. All rights reserved.
Clinical news updates from the 2008 American Heart Association Scientific Sessions; Preferential formulary listing of a proton-pump inhibitor; Drug Watch: Agents in late-stage development for the treatment of multiple sclerosis